Literature DB >> 12816800

Anecdotes as evidence.

Jeffrey K Aronson.   

Abstract

Mesh:

Year:  2003        PMID: 12816800      PMCID: PMC1126236          DOI: 10.1136/bmj.326.7403.1346

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

3.  High-dose verapamil-trandolapril induced rhabdomyolysis and acute renal failure.

Authors:  Y Gokel; S Paydas; M Duru
Journal:  Am J Emerg Med       Date:  2000-10       Impact factor: 2.469

Review 4.  Adverse drug reactions: keeping up to date.

Authors:  Jeffrey K Aronson; Sheena Derry; Yoon K Loke
Journal:  Fundam Clin Pharmacol       Date:  2002-02       Impact factor: 2.748

5.  Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum.

Authors:  G J de Klerk; M G Nieuwenhuis; J J Beutler
Journal:  BMJ       Date:  1997-03-08

Review 6.  A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors:  P Mazzotta; L A Magee
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

7.  [Ventricular tachycardia with 2 variable opposing foci].

Authors:  F Dessertenne
Journal:  Arch Mal Coeur Vaiss       Date:  1966-02

8.  The debendox saga.

Authors:  M L Orme
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

9.  Prolonged half-life of verapamil in a case of overdose: implications for therapy.

Authors:  C D Buckley; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

10.  [Diagnostic usefulness of KL-6 measurements in patients with pulmonary complications after administration of amiodarone].

Authors:  Y Endoh; R Hanai; K Uto; M Uno; H Nagashima; T Takizawa; A Narimatsu; S Ohnishi; H Kasanuki
Journal:  J Cardiol       Date:  2000-02       Impact factor: 3.159

View more
  32 in total

Review 1.  Systematic review of case reports concerning adults suffering from neutropenic enterocolitis.

Authors:  Andrés Felipe Cardona Zorrilla; Ludovic Reveiz Herault; Alexandra Casasbuenas; Diego Mauricio Aponte; Pedro Luis Ramos
Journal:  Clin Transl Oncol       Date:  2006-01       Impact factor: 3.405

Review 2.  Assessing the quality of research.

Authors:  Paul Glasziou; Jan P Vandenbroucke; Iain Chalmers
Journal:  BMJ       Date:  2004-01-03

3.  Guidelines for anecdotes might include more information.

Authors:  Sergio Abanades; Mag Farré
Journal:  BMJ       Date:  2003-08-02

4.  Time for a new approach to case reports.

Authors:  Riaz Agha; R David Rosin
Journal:  Int J Surg Case Rep       Date:  2010-05-04

5.  Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database.

Authors:  Piero Impicciatore; Massimiliano Mucci
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

6.  Write on.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

7.  Metameta-analysis.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

8.  Case reports and drug safety.

Authors:  E P van Puijenbroek
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 9.  Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.

Authors:  Yoon Kong Loke; Deirdre Price; Sheena Derry; Jeffrey K Aronson
Journal:  BMJ       Date:  2006-01-18

10.  A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone.

Authors:  Yoon K Loke; Sheena Derry; Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.